FDA approves Xifaxan for liver disease

Thursday, March 25, 2010 - 06:56 in Health & Medicine

WASHINGTON, March 25 (UPI) -- The U.S. Food and Drug Administration says it has approved Xifaxan for reducing the risk of overt hepatic encephalopathy recurrence in advanced liver disease.

Read the whole article on UPI

More from UPI

Latest Science Newsletter

Get the latest and most popular science news articles of the week in your Inbox! It's free!

Check out our next project, Biology.Net